- Cancer Drugs
- Diabetes Drugs
- Mental Illness Drugs
- Cardiovascular Disease Drugs
- Hypertension Drugs
- Inflammation Drugs
- Allergy Drugs
- Central Nervous System Drugs
- Neurology Drugs
- Asthma Drugs
- Hepatitis Drugs
- Arthritis Drugs
- Osteoporosis Drugs
- Tuberculosis Drugs
- Malaria Drugs
- Alzheimer Drugs
- Parkinson Disease Drugs
- HIV
- Multiple Sclerosis Drugs
- Autoimmune Drugs
- Insomnia Drugs
- Obesity Drugs
- Gaucher Drugs
- Anemia Drugs
- Crohn Drugs
- Huntington Drugs
- Paget Drugs
Diseases & treatment Market Research Reports
Title | published | price | |
---|---|---|---|
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... III) (Sanfilippo Syndrome ) - Drugs In Development, 2022, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) (Genetic Disorders) pipeline landscape.
Mucopolysaccharidosis type III (MPS III), also know......" | 30-Nov-2022 | $2000 | |
Usher Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Usher Syndrome (Genetic Disorders) pipeline landscape.
Usher syndrome is an inherited condition characterized by hearing impairment and progressive vision loss. The major symptoms of Usher syndrome are hearing loss and an eye disorder ca......" | 30-Nov-2022 | $2000 | |
Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... cklinghausen's Disease) - Drugs In Development, 2022, provides an overview of the Neurofibromatoses Type I (Von Recklinghausen's Disease) (Genetic Disorders) pipeline landscape.
Neurofibromatosis type 1 (NF1), also called von Recklinghau......" | 30-Nov-2022 | $2000 | |
Wilson Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Wilson Disease (Genetic Disorders) pipeline landscape.
Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. S......" | 30-Nov-2022 | $2000 | |
Global Statin Market Research Report 2022-2032By Fatpos Global "...... report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter's five force model.
This report also provides the existing competitive scenario of some of the key players of th......" | 30-Nov-2022 | $4350 | |
Global Ossotide Industry Research Report, Growth Trends and Competitive Analysis 2022-2028By QYResearch Group "...... ine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Ossot......" | 29-Nov-2022 | $5600 | |
Global Multiple Sclerosis Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "...... geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize t......" | 29-Nov-2022 | $3450 | |
Global Opium Tincture Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "...... .
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (dr......" | 29-Nov-2022 | $3450 | |
Global Brain Health Supplements Industry Research Report, Growth Trends and Competitive Analysis 2022-2028By QYResearch Group "...... e War Influence, the global market for Brain Health Supplements estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market......" | 28-Nov-2022 | $5600 | |
Global Hyperuricemia Drugs Market Research Report 2022By QYResearch Group "...... acid can result in serious diseases such as painful arthritis called gout.
Highlights
The global Hyperuricemia Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and ......" | 25-Nov-2022 | $2900 | |
|